Infrastructure for
Verifiable Biology.
Enigma Genetics builds persistent biological verification infrastructure for regulated medicine. We enable sponsors, payers, and regulators to verify participant identity, eligibility, and consent — without ever taking custody of raw genomic data.
This is not diagnostics.
This is not sequencing.
This is infrastructure for execution.
The Structural Problem
Biology Has No Native Identity Layer
We figured out how to read DNA. We never figured out how to keep using it safely.
Today, biological data is associated with administrative identity — names, dates of birth, medical record numbers. These identifiers were designed for billing, not for cryptographic continuity. Once a genome is sequenced, it becomes detached from the organism that produced it. There is no system-level guarantee that follow-up samples belong to the same individual.
In Clinical Trials
Redundant sequencing costs ($600-$3,000 per instance), exclusion of eligible participants, and protocol deviations that invalidate entire study arms.
In Insurance & Payer
Refusal to accept historical biological evidence, mandatory re-testing requirements, and delayed underwriting decisions.
In Research
Siloed datasets, inability to perform longitudinal analysis across institutions, and irreproducible findings.
The Enigma Thesis
Verification and execution have radically different cost curves. Traditional systems bundle them together, forcing physical verification every time execution is required.
Verification
Physical, regulated, high-cost, low-frequency, irreversible
Execution
Computational, repeatable, low-cost, high-frequency, compounding
Enigma front-loads verification once, then allows execution to occur indefinitely at software-level marginal cost.
For Investors
Why This Is Infrastructure, Not Biotech
Biotech companies scale by increasing lab throughput and hiring specialists. Enigma scales by increasing action density per verified identity.
The Structural Failure
- 01Eligibility must be re-proven for every trial
- 02Participant identity resets across programs
- 03Consent is fragmented, manual, and hard to audit
- 04Payers lack durable, post-therapy verification
These are infrastructure failures, not biology failures.
What Enigma Delivers
- 01Persistent Biological Identity (EBID) across time and sponsors
- 02Eligibility verification without re-screening loops
- 03Purpose-bound, revocable consent enforced at execution time
- 04Audit-grade receipts for sponsors, regulators, and payers
Sponsors pay less per outcome. Enigma earns more per identity over time.
Unit Economics of a Verified Identity
Verification Cost
$800-$1,400
One-time, per identity
Annual Maintenance
$20-$40
Storage, compute, audit
Lifetime Revenue
$3,000+
Over 5 years, sponsor-only
What We Explicitly Do Not Do
Scope discipline is the moat.
Collaboration
For Scientists & Partners
Enigma provides consent-verified, longitudinal biological data infrastructure for regulated research and commercial execution.
Data Access
- Consent-verified longitudinal profiles
- Immutable provenance trails
- Zero-knowledge interaction models
- Encrypted collaboration channels
Execution
- Compute-to-data architecture
- Reference-aligned delta queries
- Sub-linear cohort comparison
- Audit-grade execution receipts
For Scientists
Access anonymized, consent-verified datasets for longitudinal research. Raw data never leaves the originating lab. Queries run against verified delta representations only.
For Partners
Integrate our persistent biological identity infrastructure into your clinical, therapeutic, or reimbursement workflows. Verification once, execution indefinitely.
Join Us
Get Involved
Enigma is assembling the infrastructure layer for verifiable biology. If you believe in building real systems over narrative, there is a place here.
Careers
Multidisciplinary team building at the intersection of biology, cryptography, and systems.
View OpeningsUpdates
Follow Enigma's progress from architecture to execution.
Contact
Ready to Learn More?
If you invest in infrastructure over narrative, we should talk.
Biological verification infrastructure for regulated medicine.
Patent Pending: System and Method for Self-Sovereign Genetic Identity, Epigenetic Mapping, and Consent-Controlled Data Exchange
Cypherglyph, GeneVault, SignaChain, Unifacator, and OmniMind are trademarks of Enigma Genetics LLC.
Disclaimer: Not for diagnostic or medical use. Designed for research and identity verification purposes only.